Quercetin reverses tamoxifen resistance in breast cancer cells

Journal of B.U.ON.

Volumn 20, Issue 3, 2015, Pages 707-713

  Wang, Hongxian ^a   Tao, Linyu ^a   Qi, Ke ^a   Zhang, Haoyun ^a   Feng, Duo ^a   Wei, Wenjun ^a   Kong, Heng ^a   Chen, Tianwen ^a   Lin, Qiusheng ^a  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Endocrine therapy; Quercetin; Tamoxifen resistance

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR ALPHA; QUERCETIN; TAMOXIFEN; AFIMOXIFENE; ANTIESTROGEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; ERBB2 PROTEIN, HUMAN; ESTROGEN RECEPTOR ALPHA, HUMAN;

APOPTOSIS; ARTICLE; BREAST CANCER CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; BREAST TUMOR; DOSE RESPONSE; DRUG EFFECTS; DRUG RESISTANCE; FEMALE; MCF 7 CELL LINE; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TIME;

ANTINEOPLASTIC AGENTS, HORMONAL; APOPTOSIS; BREAST NEOPLASMS; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; MCF-7 CELLS; QUERCETIN; RECEPTOR, ERBB-2; SIGNAL TRANSDUCTION; TAMOXIFEN; TIME FACTORS;

EID: 84938700552     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Tanic N, Milovanovic Z, Tank N et al. The impact of PTEN tumor suppressor gene on acquiring resistance to tamoxifen treatment in breast cancer patients. Cancer Biol Ther 2012; 13:1165-1174.
2. Nesković-Konstantinović Z, Susnjar S, Nikolić-Vukosavljevic D et al. Primarily tamoxifen-unrespon-sive, steroid receptor-positive breast cancer may respond to an aromatase inhibition: a pilot study. JBUON 2005; 10:53-58.
3. Rajeshwar Rao Tekmal. Targeting Aldose Reductase: A Novel Strategy in Treating Endocrine Resistance Using Combination Therapy. The 2009 San Antonio Breast Cancer Symposium (SABCS), San Antonio, Dec. 11, 2009.
4. Firdous AB, Sharmila G, Balakrishnan S et al. Quercetin, a natural dietary flavonoid, acts as a chemopre-ventive agent against prostate cancer in an in vivo model by inhibiting the EGFR signaling pathway. Food Funct 2014; 5:2632-2645.
5. Castillo-Pichardo L, Martínez-Montemayor MM, Martinez JE et al. Inhibition of mammary tumor growth and metastases to bone and liver by dietary grape polyphenols. Clin Exp Metastasis 2009; 26:505-516.
6. Pampaloni B, Palmini G, Mavilia C et al. In vitro effects of polyphenols on colorectal cancer cells. World J Gastrointest Oncol 2014; 6:289-300.
7. Kim MC, Lee HJ, Lim B et al. Quercetin induces apoptosis by inhibiting MAPKs and TRPM7 channels in AGS cells. Int J Mol Med 2014; 33:1657-1663.
8. Ansó E, Zuazo A, Irigoyen M et al. Flavonoids inhibit hypoxia-induced vascular endothelial growth factor expression by a HIF-1 independent mechanism. Biochem Pharmacol 2010; 79:1600-1609.
9. Jeong JH, An JY, Kwon YT et al. Quercetin-induced ubiquitination and down-regulation of Her-2/neu. J Cell Biochem 2008; 105:585-595.
10. Rachel S, Suleiman M, Jiang S et al. Breast Cancer Endocrine Resistance: How Growth Factor Signaling and Estrogen Receptor Coregulators Modulate Response. Clin Cancer Res 2003; 9 (Suppl): 447-454.
11. Garcia-Becerra R, Santos N, Diaz L et al. Mechanisms of Resistance to Endocrine Therapy in Breast Cancer: Focus on Signaling Pathways, miRNAs and Genetically Based Resistance Int J Mol Sci 2012; 14:108-145.
12. Zhang B, Zhang X, Tang B et al. Investigation of elemene-induced reversal of tamoxifen resistance in MCF-7 cells through oestrogen receptor a (ERa) re-expression. Breast Cancer Res Treat 2012; 136:399-406.
13. Vesuna F, Lisok A, Kimble B et al. Twist contributes to hormone resistance in breast cancer by downregulating estrogen receptor-a. Oncogene 2012; 31:3223-3234.
14. Hurtado AI, Holmes KA, Geistlinger TR et al. Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen. Nature 2008; 456:663-666.
15. Brodie A, Jelovac D, Sabnis G et al. Model systems: mechanisms involved in the loss of sensitivity to letrozole. J Steroid Biochem Mol Biol 2005; 95:41-48.
16. Orphanos G, Kakoullou N, Ardavanis A et al. Is overcoming hormone resistance in breast cancer possible? JBUON 2008; 13:315-322.
17. Sheng ZG, Zhu BZ. Low concentration of bisphenol a induce mouse spermatogonial cell proliferation by G-Protein-coupled receptor 30 and estrogen recepor-a. Environ Health Perspect 2011; 119:1775-1780.
18. James R, Thriveni K, Krishnamoorthy L et al. Clinical outcome of adjuvant endocrine treatment according to Her-2/neu status in breast cancer. Indian J Med Res 2011; 133:70-75.
19. Moreira L, Araújo I, Costa T et al. Quercetin and epigallocatechin gallate inhibit glucose uptake and metabolism by breast cancer cells by an estrogen receptor-independent mechanism. Exp Cell Res 2013; 319:1784-1795.